678 583


475 470

По вашему запросу найдено документов: 241328

Страница 1 из 24133

Arginase inhibitor in the pharmacological correction of endothelial dysfunctionThis paper is about a way of correction of endothelial dysfunction with the inhibitor of arginase

The study of the endothelial protective properties of the L-norvaline combination with mexidol in the simulation of L-NAME-induced NO deficiencyThe endothelium is considered as a target for the prevention and treatment of pathological

Concomitant use of statins and s-(2-boron-ethyl)-l-cysteine arginase inhibitor to correct endotoxin-induced endothelial dysfunctionThe concomitant use of non-selective S-(2-boron-ethyl)-L-cysteine (BEC) arginase inhibitor

Endothelium and cardioprotective effects of hmg-co-a-reductase in combination with l-arginine In endothelial dysfunction modelingUsing the combined application of L-arginine with HMG-Co-A reductase inhibitors simvastatin

The research of abnormal toxicity and local irritant effect in the Draize test of the drug furacilin, concentrate for the preparation of a solution for local and externaluse for the preparation of a solution for local and external use in comparison with the drug Furacilin, tablets

Tendencies and prospects of public-private partnership development in the field of physical culture and sport) to be a perspective form of cooperation between the state and the private sector in the aspect

The cardio- and endothelial protective effects of ethyl methyl hydroxyl pyridine malate in modeling L-name induced nitric oxide deficiencyCurrently, endothelial dysfunction is considered as a predictor of a number of pathologies

Evaluation of cardioprotective effects of the incritinmimetics exenatideand vildagliptin in the experiment

Use of selective inhibitors of arginase 2 and tadalafil in combined compensation of homocysteine-induced endothelial dysfunction

Pharmacological correction of L-NAME-induced oxide deficiency with derivatives of 3-(2,2,2-trimethylhydrazinium) propionate

Страница 1 из 24133